-
Dr Thierry Menguy, PhD, Head of mAb Development and Production Unit and co-founder of ELSALYS BIOTECH, has presented "Anti-CD160 alone or in combination with anti-VEGF is a potent inhibitor of ocular neovascularisation in rabbit and monkey models
